| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |